Abstract
Purpose: The main characteristics of mechanically ventilated ARDS patients affected with COVID-19, and the adherence to lung-protective ventilation strategies are not well known. We describe characteristics and outcomes of confirmed ARDS in COVID-19 patients managed with invasive mechanical ventilation (MV).
Methods: This is a multicenter, prospective, observational study in consecutive, mechanically ventilated patients with ARDS (as defined by the Berlin criteria) affected with with COVID-19 (confirmed SARS-CoV-2 infection in nasal or pharyngeal swab specimens), admitted to a network of 36 Spanish and Andorran intensive care units (ICUs) between March 12 and June 1, 2020. We examined the clinical features, ventilatory management, and clinical outcomes of COVID-19 ARDS patients, and compared some results with other relevant studies in non-COVID-19 ARDS patients.
Results: A total of 742 patients were analysed with complete 28-day outcome data: 128 (17.1%) with mild, 331 (44.6%) with moderate, and 283 (38.1%) with severe ARDS. At baseline, defined as the first day on invasive MV, median (IQR) values were: tidal volume 6.9 (6.3-7.8) ml/kg predicted body weight, positive end-expiratory pressure 12 (11-14) cmH 2 O. Values of respiratory system compliance 35 (27-45) ml/cmH 2 O, plateau pressure 25 (22-29) cmH 2 O, and driving pressure 12 (10-16) cmH 2 O were similar to values from non-COVID-19 ARDS patients observed in other studies. Recruitment maneuvers, prone position and neuromuscular blocking agents were used in 79%, 76% and 72% of patients, respectively. The risk of 28-day mortality was lower in mild ARDS [hazard ratio (RR) 0.56 (95% CI 0.33-0.93), p = 0.026] and moderate ARDS [hazard ratio (RR) 0.69 (95% CI 0.47-0.97), p = 0.035] when compared to severe ARDS. The 28-day mortality was similar to other observational studies in non-COVID-19 ARDS patients.
Conclusions: In this large series, COVID-19 ARDS patients have features similar to other causes of ARDS, compliance with lung-protective ventilation was high, and the risk of 28-day mortality increased with the degree of ARDS severity.
Trial registration: ClinicalTrials.gov NCT04368975 .
Keywords: Acute respiratory distress syndrome; Coronavirus; Mechanical ventilation; Outcome.
【저자키워드】 coronavirus, acute respiratory distress syndrome, mechanical ventilation, outcome, 【초록키워드】 Prone position, ARDS, SARS-COV-2 infection, severity, intensive care unit, 28-day mortality, risk, nasal, outcome, observational study, Clinical features, Clinical outcome, Characteristics, management, Patient, Compliance, Mild, Respiratory system, multicenter, moderate, specimens, patients, Invasive mechanical ventilation, distress, COVID-19 patient, Positive end-expiratory pressure, Volume, Pharyngeal swab, 95% CI, severe ARDS, ICUs, ventilatory, Berlin criteria, mechanically ventilated, driving, Spanish, Complete, feature, value, invasive, blocking agent, defined, predicted, affected, examined, analysed, median, were used, cause, ARDS patient, baseline, COVID-19 ARDS patient, COVID-19 ARDS patients, IQR, lung-protective ventilation, Mechanical, mechanically ventilated patient, non-COVID-19 ARDS patient, non-COVID-19 ARDS patients, with COVID-19, 【제목키워드】 COVID-19, ARDS, outcome, Features, clinical, management, ventilatory, caused, cause,